Current Problems in Diagnostic Radiology
Volume 35, Issue 4 , Pages 151-163 , July 2006

Positron Emission Tomography/Computed Tomography in the Management of Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

  • Beatriz Rodríguez-Vigil, MD

      Affiliations

    • Department of Radiology, University hospital “La Paz”, Madrid, Spain
    • Corresponding Author InformationReprint requests: Beatriz Rodríguez-Vigil, MD, Department of Radiology, University hospital “La Paz”, Paseo de la Castellana, 261, 28046 Madrid, Spain.
    • ,
  • Nieves Gómez-León, MD, PhD

      Affiliations

    • Department of Radiology, University hospital “La Paz”, Madrid, Spain
    • ,
  • Inmaculada Pinilla, MD, PhD

      Affiliations

    • Department of Radiology, University hospital “La Paz”, Madrid, Spain
    • ,
  • Dolores Hernández-Maraver, MD

      Affiliations

    • Department of Haematology, University hospital “La Paz”, Madrid, Spain
    • ,
  • Juan Coya, MD

      Affiliations

    • Department of Nuclear Medicine, University hospital “La Paz”, Madrid, Spain
    • ,
  • Luis Martín-Curto, MD, PhD

      Affiliations

    • Department of Nuclear Medicine, University hospital “La Paz”, Madrid, Spain

References 

  1. Segall GM . FDG PET imaging in patients with lymphoma (A clinical perspective) . J Nucl Med . 2001;42:609–610
  2. Hoskin PJ . PET in lymphoma (What are the oncologist’s needs?) . Eur J Nucl Med Mol Imaging . 2003;30:128–130
  3. Ping L . Staging and classification of lymphoma . Semin Nucl Med . 2005;35:160–164
  4. Beyer T , Townsend DW , Brun T , et al.   A combined PET/CT scanner for clinical oncology . J Nucl Med . 2000;41:1369–1379
  5. Townsend DW , Beyer T . A combined PET/CT scanner (The path to true image fusion) . Br J Radiol . 2002;75:24–30
  6. Hany TF , Steinert HC , Goerres GW , et al.   PET diagnostic accuracy: Improvement with in-line PET-CT system: initial results . Radiology . 2002;225:575–581
  7. Israel O , Mor M , Gaitini D , et al.   Combined functional and structural evaluation of cancer patients with hybrid camera-based PET/CT system using (18)F-FDG . J Nucl Med . 2002;43:1129–1136
  8. Bar-Shalom R , Yefremov N , Guralnik L , et al.   Clinical performance of PET/CT in evaluation of cancer (Additional value for diagnostic imaging and patient management) . J Nucl Med . 2003;44:1200–1209
  9. Charron M , Beyer T , Bohnen NN , et al.   Image analysis in patients with cancer studied with a combined PET and CT scanner . Clin Nucl Med . 2000;25:905–910
  10. Bristow RE , del Carmen MG , Pannu HK , et al.   Clinically occult recurrent ovarian cancer (Patient selection for secondary cytoreductive surgery using combined PET/CT) . Gynecol Oncol . 2003;90:519–528
  11. Makhija S , Howden N , Edwards R , et al.   Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma (A retrospective review) . Gynecol Oncol . 2002;85:53–58
  12. Patel PV , Cohade C , Chin BB . PET/CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma . Gynecol Oncol . 2002;87:323–326
  13. Tatsumi M , Cohade C , Nakamoto Y , et al.   Direct comparison of FDG PET and CT findings in patients with lymphoma (Initial experience) . Radiology . 2005;237:1038–1045
  14. Kapoor V , McCook BM , Torok FS . An introduction to PET/CT imaging . Radiographics . 2004;24:523–543
  15. Cook GJR , Wegner EA , Fogelman I . Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging . Semin Nucl Med . 2004;34:122–133
  16. Cohade C , Wahl RL . Applications of PET/CT image fusion in clinical PET—clinical use, interpretation methods, diagnostic improvements . Semin Nucl Med . 2003;33:228–237
  17. Antoch G , Beyer T , Freudenberg S , et al.   PET/CT or CT/PET? A radiologist’s perspective . Electromedica . 2003;71:64–69
  18. Townsend DW , Beyer T , Blodgett T . PET/CT scanners (A hardware approach to image fusion) . Semin Nucl Med . 2003;33:193–204
  19. Wiley G . Disruptive technology (The conflict over PET/CT) . Imaging Econ . 2005;1:1–10
  20. Czernin J , Schelbert H . PET/CT imaging (Facts, opinions, hopes, and questions) . J Nucl Med . 2004;45:1–3
  21. Antoch G , Freudenberg LS , Beyer T , et al.   To enhance or not to enhance?18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT . J Nucl Med . 2004;45:56–65
  22. Beyer T , Antoch G , Bockisch A , et al.   Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT . J Nucl Med . 2005;46:429–435
  23. Antoch G , Freudenberg LS , Stattaus J , et al.   Whole-body PET/CT (Optimized CT using oral and IV contrast materials) . AJR . 2002;179:1555–1561
  24. Nakamoto Y , Chin BB , Kraitchman D , et al.   Effects of non-ionic intravenous contrast agents at PET/CT imaging (Phantom and canine studies) . Radiology . 2003;227:817–824
  25. Yau YY , Coel M , Chan WS , et al.   Application of IV contrast in PET/CT (Does it really produce attenuation correction error?) . J Nucl Med . 2003;44:1–8
  26. Dizendorf E , Hany TF , Buck A , et al.   Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies . J Nucl Med . 2003;44:732–738
  27. Dizendorf DV , Treyer V , Von Schulthess GK , et al.   Application of oral contrast media in coregistered postitron emission tomography-CT . AJR . 2002;179:477–481
  28. Moog F , Bangerter M , Kotzerke J , et al.   18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow . J Clin Oncol . 1998;16:603–609
  29. Schöder H , Noy A , Gönen M , et al.   Intensity of fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma . J Clin Oncol . 2005;23:4643–4651
  30. Raanani P , Shasha T , Perry C , et al.   Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? . Ann Oncol . 2006;17:117–122
  31. Allen-Auerbach M , Quon A , Weber WA , et al.   Comparison between 2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma . Mol Imag Biol . 2004;6:411–416
  32. Tatsumi M , Cohade C , Nakamoto Y , et al.   Direct comparison of FDG PET and CT findings in patients with lymphoma (initial experience) . Radiology . 2005;237:1038–1045
  33. Schaefer NG , Hany TF , Taverna C , et al.   Non-Hodgkin lymphoma and Hodgkin disease (Coregistered FDG PET and CT at staging and restaging—do we need contrast enhanced CT?) . Radiology . 2004;232:823–829
  34. Ell PJ . The contribution of PET/CT to improved patient management . Br J Radiol . 2006;79:32–36
  35. Elstrom R , Guan L , Baker G , et al.   Utility of FDG-PET scanning in lymphoma by WHO classification . Blood . 2003;101:3875–3876
  36. Rodríguez M , Rehn S , Ahlstrom H , et al.   Predicting malignancy grade with PET in non-Hodgkin’s lymphoma . J Nucl Med . 1995;36:1790–1796
  37. Freudenberg LS , Antoch G , Schütt P , et al.   FDG-PET/CT in re-staging of patients with lymphoma . Eur J Nucl Med Mol Imaging . 2004;31:325–329
  38. Spaepen K , Stroobants S , Dupont P , et al.   Early restaging PET with 18F-FDG predicts outcome in patients with aggressive non-Hodgkin’s lymphoma . Ann Oncol . 2002;13:1356–1363
  39. Torizuka T , Nakamura F , Kanno T , et al.   Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma . Eur J Nucl Med Mol Imag . 2004;31:22–27
  40. Haioun C , Itti E , Rahmouni A , et al.   18F-FDG PET in aggressive lymphoma (An early prognostic tool for predicting patient outcome) . Blood . 2005;106:1376–1381
  41. Castellucci P , Nanni C , Farsad M , et al.   Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma (Prevalence and scan interpretation) . Nucl Med . 2005;26:689–694
  42. Naumann R , Vaic A , Beuthien-Baumann B , et al.   Prognostic value of PET in the evaluation of post-treatment residual mass in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma . Br J Haematol . 2001;115:793–800
  43. Jerusalem G , Beguin Y , Fassotte MF , et al.   Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease . Ann Oncol . 2003;14:123–130
  44. Wittram C , Fischman AJ , Mark E , et al.   Thymic enlargement and FDG uptake in 3 patients (CT and FDG PET correlated with pathology) . AJR . 2003;180:519–522
  45. Goerres GW , Kamel E , Heidelberg TN , et al.   PET/CT image co-registration in the thorax (Influence of respiration) . Eur J Nucl Med . 2002;29:351–360
  46. Goerres GW , Burger C , Schwitter MR , et al.   PET/CT of the abdomen (optimizing the patient breathing pattern) . Eur Radiol . 2003;13:734–739
  47. Osman MM , Cohade C , Nakamoto Y , et al.   Clinically significant inaccurate localization of lesions with PET/CT (Frequency in 300 patients) . J Nucl Med . 2003;44:240–244
  48. Goerres GW , Burger C , Kamel E , et al.   Respiration-induced attenuation artifact at PET/CT (Technical considerations) . Radiology . 2003;226:906–910

PII: S0363-0188(06)00010-7

doi: 10.1067/j.cpradiol.2006.02.001

Current Problems in Diagnostic Radiology
Volume 35, Issue 4 , Pages 151-163 , July 2006

Article Tools

* Image Usage & Resolution